CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
CNBX Pharmaceuticals's profit margin for the twelve months ending Nov 30, 2024 was -1356.0%. For fiscal 2024 it was -534.5%, against -904.6% the year before. The highest annual figure on record is 11510.4% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Aug 31, 2024 | -534.5% | +370.1 |
| FY2023 | Aug 31, 2023 | -904.6% | +11523.7 |
| FY2022 | Aug 31, 2022 | -12428.2% | +91909.7 |
| FY2020 | Aug 31, 2020 | -104337.9% | −115848.3 |
| FY2019 | Aug 31, 2019 | 11510.4% | +50846.1 |
| FY2018 | Aug 31, 2018 | -39335.7% | −5313.1 |
| FY2017 | Aug 31, 2017 | -34022.5% | −33749.5 |
| FY2016 | Aug 31, 2016 | -273.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | -800.9% | +800.4 |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | -199.6% | +32955.3 |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | -573.6% | +37903.4 |
| Q3 FY2023CQ2 2023 | May 31, 2023 | -49.9% | +66199.4 |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | -1601.3% | +291568.3 |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | -33154.9% | +34545.4 |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -38476.9% | −13132.1 |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -66249.2% | −227010.7 |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -293169.6% | −273321.7 |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -67700.3% | −42927.9 |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -25344.9% | +4146.8 |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | 160761.5% | +245436.1 |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -19848.0% | +10726.8 |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -24772.4% | +13663.1 |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -29491.7% | −13869.3 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -84674.7% | −49413.2 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -30574.7% | −30437.7 |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -38435.5% | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -15622.4% | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -35261.5% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -137.0% | – |
See a number that looks wrong?